Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonella Scalone

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Blood Medicine|January 28, 2012
Boosting platelet inhibition in poor responder to aspirin and clopidogrel undergoing percutaneous coronary intervention: role of tirofibanGianluca Campo, Luca Fileti, Marco Valgimigli, et al.
The American Journal of Cardiology|February 4, 2017
Frequency of "Pocket" Hematoma in Patients Receiving Vitamin K Antagonist and Antiplatelet Therapy at the Time of Pacemaker or Cardioverter Defibrillator Implantation (from the POCKET Study)Michele Malagù, Filippo Trevisan, Antonella Scalone, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 29, 2014
A migrant left ventricular leadMichele Malagù, Lina Marcantoni, Antonella Scalone, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 28, 2008
Safety and efficacy of ezetimibe with low doses of simvastatin in heart transplant recipientsCandida C Quarta, Luciano Potena, Francesco Grigioni, et al.
Transplantation|April 24, 2008
Long-term effect of folic acid therapy in heart transplant recipients: follow-up analysis of a randomized studyLuciano Potena, Francesco Grigioni, Marco Masetti, et al.
JACC. Cardiovascular Interventions|December 17, 2013
Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY)Marco Valgimigli, Matteo Tebaldi, Marco Borghesi, et al.
Circulation|March 23, 2012
Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trialMarco Valgimigli, Gianluca Campo, Monia Monti, et al.
American Heart Journal|November 25, 2010
Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention Design and rationale for the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia study (PRODIGY)Marco Valgimigli, Gianluca Campo, Gianfranco Percoco, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Blood Medicine|January 28, 2012
Boosting platelet inhibition in poor responder to aspirin and clopidogrel undergoing percutaneous coronary intervention: role of tirofibanGianluca Campo, Luca Fileti, Marco Valgimigli, et al.
The American Journal of Cardiology|February 4, 2017
Frequency of "Pocket" Hematoma in Patients Receiving Vitamin K Antagonist and Antiplatelet Therapy at the Time of Pacemaker or Cardioverter Defibrillator Implantation (from the POCKET Study)Michele Malagù, Filippo Trevisan, Antonella Scalone, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 29, 2014
A migrant left ventricular leadMichele Malagù, Lina Marcantoni, Antonella Scalone, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 28, 2008
Safety and efficacy of ezetimibe with low doses of simvastatin in heart transplant recipientsCandida C Quarta, Luciano Potena, Francesco Grigioni, et al.
Transplantation|April 24, 2008
Long-term effect of folic acid therapy in heart transplant recipients: follow-up analysis of a randomized studyLuciano Potena, Francesco Grigioni, Marco Masetti, et al.
JACC. Cardiovascular Interventions|December 17, 2013
Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY)Marco Valgimigli, Matteo Tebaldi, Marco Borghesi, et al.
Circulation|March 23, 2012
Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trialMarco Valgimigli, Gianluca Campo, Monia Monti, et al.
American Heart Journal|November 25, 2010
Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention Design and rationale for the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia study (PRODIGY)Marco Valgimigli, Gianluca Campo, Gianfranco Percoco, et al.
Pageof 1